Compare Quest Diagnostics Inc (DGX) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Quest Diagnostics Inc trades at $204.95 (market cap $22.80B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $107.44. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| DGX | LQD | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | — |
52-Week High | $216.02 | $112.91 |
52-Week Low | $166.42 | $106.96 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LQD, the iShares iBoxx $ Investment Grade Corporate Bond ETF, trades at $106.96, down 0.47% on the day. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators suggest potential oversold conditions. Recent dividend payouts of $0.38-$0.42 per share highlight its income focus. Fixed income ETFs are gaining investor attention amid economic resilience and rate uncertainty, with bond inflows surging 60% year-over-year as of June 2026 (CNBC, 2026-06-25).
Outlook: LQD offers exposure to investment-grade corporate bonds with steady dividends, but faces headwinds from potential Fed rate hikes and inflation concerns. Risks include interest rate sensitivity and narrowing market breadth. Analyst comparisons favor LQD for lower drawdowns versus peers, but investors should weigh yield against Treasury alternatives. The ETF's performance hinges on macroeconomic policy shifts and corporate debt market stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
